American pharmaceutical company NXT USA and Shanghai Freemen, an industry leading global supplier of ingredients, have partnered to launch Digexin on 2-3rd November at SupplySide West, in Las Vegas.
Backed by a gold standard double-blind, placebo-controlled human study pending publication, Digexin is validated to improve digestion and enhance mood and other quality of life measures. Further, a second larger clinical trial is currently underway to further demonstrate Digexin’s benefits.
“Digexin is a new approach in the in the digestive category, promoting regularity while also promoting mood, sleep and stress support,” said Eric Anderson, Managing Director, NXT USA. “We are excited to partner with Shanghai Freemen to expand the market for consumers that desire both benefits. For many people, this can be the difference between a good day, and a not-so-good day!”
Hanks Li, President of Shanghai Freemen America, said: “We are excited to be bringing Digexin to market with an accomplished partner like NXT USA. As our first proprietary ingredient, we see substantial potential in Digexin and its clinically validated benefits. This is an important step as we expand our capabilities to meet evolving customer needs.”
For many people, this can be the difference between a good day, and a not-so-good day
The clinical study showed tangible results across multiple measures. Compared to placebo, the benefits demonstrated by Digexin included reduced constipation symptoms, improved sense of complete evacuation, better quality of sleep and improved quality of life.
“Our first human study produced the statistically significant results in healthy subjects we anticipated, so we are even more excited about the larger clinical trial currently underway to confirm and validate Digexin’s benefits,” Anderson added. “For consumers not satisfied with existing gut health products due to efficacy, side effects, or simply needing additional action, Digexin provides a new choice.”
Digexin will be showcased at SupplySide West at the Shanghai Freemen Booth #7111.
